Bimiralisib
CAS: 1225037-39-7
Ref. TM-T2265
1mg | 42.00 € | ||
2mg | 56.00 € | ||
5mg | 89.00 € | ||
10mg | 120.00 € | ||
25mg | 216.00 € | ||
50mg | 364.00 € | ||
100mg | 548.00 € | ||
500mg | 1,194.00 € |
Product Information
- 5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine, PQR309, PI3K-IN-2
Bimiralisib (PI3K-IN-2) is an orally bioavailable pan inhibitor of PI3K and inhibitor of the mTOR, with potential antineoplastic activity. PI3K-IN-2 inhibits the PI3K kinase isoforms alpha, beta, gamma and delta and, to a lesser extent, mTOR kinase, which may result in tumor cell apoptosis and growth inhibition in cells overexpressing PI3K/mTOR. Activation of the PI3K/mTOR pathway promotes cell growth, survival, and resistance to both chemotherapy and radiotherapy.
Chemical properties
Technical inquiry about: TM-T2265 Bimiralisib
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.